20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is FELBAMATE, USP, with a corresponding US DMF Number 31181.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2017, and payment made on December 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II